Geneos Wealth Management’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $189K | Hold |
4,899
| – | – | ﹤0.01% | 975 |
|
|
2025
Q4 | $201K | Hold |
4,899
| – | – | ﹤0.01% | 926 |
|
|
2025
Q3 | $182K | Hold |
4,899
| – | – | ﹤0.01% | 929 |
|
|
2025
Q2 | $179K | Sell |
4,899
-1,633
| -25% | -$59.2K | ﹤0.01% | 1035 |
|
|
2025
Q1 | $252K | Buy |
6,532
+4,899
| +300% | +$194K | ﹤0.01% | 1132 |
|
|
2024
Q4 | $61.9K | Hold |
1,633
| – | – | ﹤0.01% | 1238 |
|
|
2024
Q3 | $68.5K | Buy |
1,633
+650
| +66% | +$27K | ﹤0.01% | 1083 |
|
|
2024
Q2 | $40.2K | Hold |
983
| – | – | ﹤0.01% | 1142 |
|
|
2024
Q1 | $40.7K | Hold |
983
| – | – | ﹤0.01% | 1140 |
|
|
2023
Q4 | $39.8K | Sell |
983
-409
| -29% | -$15.6K | ﹤0.01% | 1130 |
|
|
2023
Q3 | $54.5K | Sell |
1,392
-575
| -29% | -$22.9K | ﹤0.01% | 1055 |
|
|
2023
Q2 | $79.9K | Hold |
1,967
| – | – | ﹤0.01% | 939 |
|
|
2023
Q1 | $82.3K | Hold |
1,967
| – | – | 0.01% | 907 |
|
|
2022
Q4 | $85.7K | Hold |
1,967
| – | – | 0.01% | 871 |
|
|
2022
Q3 | $76K | Sell |
1,967
-850
| -30% | -$36.2K | 0.01% | 879 |
|
|
2022
Q2 | $121K | Sell |
2,817
-183
| -6% | -$7.95K | 0.01% | 938 |
|
|
2022
Q1 | $136K | Buy |
3,000
+50
| +2% | +$2.22K | 0.01% | 962 |
|
|
2021
Q4 | $143K | Sell |
2,950
-65
| -2% | -$3.08K | 0.01% | 1026 |
|
|
2021
Q3 | $143K | Hold |
3,015
| – | – | 0.01% | 1005 |
|
|
2021
Q2 | $147K | Sell |
3,015
-676
| -18% | -$32.3K | 0.01% | 988 |
|
|
2021
Q1 | $177K | Hold |
3,691
| – | – | ﹤0.01% | 1023 |
|
|
2020
Q4 | $135K | Buy |
3,691
+701
| +23% | +$31.8K | 0.01% | 1000 |
|
|
2020
Q3 | $126K | Buy |
2,990
+300
| +11% | +$12.8K | 0.01% | 850 |
|
|
2020
Q2 | $108K | Buy |
2,690
+925
| +52% | +$37.3K | 0.01% | 886 |
|
|
2020
Q1 | $62K | Buy |
1,765
+940
| +114% | +$37.5K | ﹤0.01% | 1032 |
|
|
2019
Q4 | $34K | Hold |
825
| – | – | ﹤0.01% | 1444 |
|
|
2019
Q3 | $31K | Buy |
825
+125
| +18% | +$4.81K | ﹤0.01% | 1402 |
|
|
2019
Q2 | $27K | Hold |
700
| – | – | ﹤0.01% | 1481 |
|
|
2019
Q1 | $27K | Buy |
700
+100
| +17% | +$3.95K | ﹤0.01% | 1427 |
|
|
2018
Q4 | $21K | Buy |
600
+200
| +50% | +$7.86K | ﹤0.01% | 1477 |
|
|
2018
Q3 | $17K | Buy |
400
+100
| +33% | +$4.05K | ﹤0.01% | 1643 |
|
|
2018
Q2 | $11K | Sell |
300
-100
| -25% | -$3.62K | ﹤0.01% | 1670 |
|
|
2018
Q1 | $14K | Sell |
400
-125
| -24% | -$4.45K | ﹤0.01% | 1523 |
|
|
2017
Q4 | $19K | Sell |
525
-300
| -36% | -$10.8K | ﹤0.01% | 1392 |
|
|
2017
Q3 | $30K | Buy |
825
+100
| +14% | +$3.64K | ﹤0.01% | 1164 |
|
|
2017
Q2 | $26K | Sell |
725
-950
| -57% | -$33.3K | ﹤0.01% | 1169 |
|
|
2017
Q1 | $57K | Sell |
1,675
-300
| -15% | -$10.1K | 0.01% | 839 |
|
|
2016
Q4 | $62K | Hold |
1,975
| – | – | 0.01% | 756 |
|
|
2016
Q3 | $67K | Sell |
1,975
-100
| -5% | -$3.53K | 0.01% | 706 |
|
|
2016
Q2 | $74K | Buy |
2,075
+200
| +11% | +$7.31K | 0.01% | 677 |
|
|
2016
Q1 | $67K | Buy |
+1,875
| New | +$66.2K | 0.01% | 698 |
|
Other funds holding BME
1CP
NRW
KIM
Geneos Wealth Management's BME Position: Q1 2026 in Review
Geneos Wealth Management held its BlackRock Health Sciences Trust (BME) position steady in Q1 2026 at 4,899 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #975.
Geneos Wealth Management first reported a position in BME in Q1 2016 and has held it in 41 quarters since. The position peaked at $252K in Q1 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.
- Geneos Wealth Management held 4,899 shares of BlackRock Health Sciences Trust worth $189K as of Q1 2026.
- Geneos Wealth Management left its BlackRock Health Sciences Trust share count unchanged in Q1 2026.
- BlackRock Health Sciences Trust made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #975 holding.
- Geneos Wealth Management first reported a position in BlackRock Health Sciences Trust in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's BlackRock Health Sciences Trust position peaked at $252K in Q1 2025.
- 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.